0001104659-15-025167.txt : 20150402
0001104659-15-025167.hdr.sgml : 20150402
20150401181308
ACCESSION NUMBER: 0001104659-15-025167
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20141231
FILED AS OF DATE: 20150402
DATE AS OF CHANGE: 20150401
EFFECTIVENESS DATE: 20150402
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 15744650
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
12-31-2014
12-31-2014
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Administrative Managing Director, Versant Venture Management
(415) 801-8083
/s/ Robin L. Praeger
San Francisco
CA
03-31-2015
0
5
111097158
false
INFORMATION TABLE
2
a15-8407_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
45630648
814833
SH
OTR
0
814833
0
Five Prime Therapeutics, Inc.
Common Stock
33830X104
29488104
1092152
SH
OTR
0
1092152
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
10307748
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
16719034
1281152
SH
OTR
0
1281152
0
Kythera Biopharmaceuticals, Inc.
Common Stock
501570105
2440640
70376
SH
OTR
0
70376
0